ReviewFrontiers in pharmacology2019

Analysis of Patents Issued in China for Antihyperglycemic Therapies for Type 2 Diabetes Mellitus.

Wei Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.